Stratec SE (STSEY)
OTCMKTS
· Delayed Price · Currency is USD
5.24
-1.46 (-21.79%)
At close: Nov 21, 2024
Stratec SE Revenue
In the year 2024, Stratec SE had annual revenue of 257.62M EUR, down -4.73%. Stratec SE had revenue of 81.32M in the quarter ending December 31, 2024, a decrease of -1.71%.
Revenue
257.62M EUR
Revenue Growth
-4.73%
P/S Ratio
1.39
Revenue / Employee
185.74K EUR
Employees
1,387
Market Cap
369.56M USD
Revenue Chart
* This company reports financials in EUR.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 257.62M | -12.79M | -4.73% |
Dec 31, 2023 | 270.41M | -4.21M | -1.53% |
Dec 31, 2022 | 274.63M | -12.71M | -4.42% |
Dec 31, 2021 | 287.34M | 37.24M | 14.89% |
Dec 31, 2020 | 250.10M | 35.94M | 16.78% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Endo Inc. | 1.73B |
Veradigm | 588.02M |
Tian'an Technology Group | 1.78M |
Elite Pharmaceuticals | 70.00M |
Glass House Brands | 215.62M |
Northwest Biotherapeutics | 1.47M |
American Oncology Network | 1.76B |
Silence Therapeutics | 27.70M |